Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Humana stock

HUM.ST
SE0008040653
A2AFX9

Price

35.51
Today +/-
-0.09
Today %
-3.02 %

Humana stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Humana stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Humana stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Humana stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Humana's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Humana Stock Price History

DateHumana Price
12/19/202435.51 undefined
12/18/202436.60 undefined
12/17/202435.40 undefined
12/16/202436.35 undefined
12/13/202436.90 undefined
12/12/202436.40 undefined
12/11/202436.65 undefined
12/10/202436.50 undefined
12/9/202436.65 undefined
12/6/202437.10 undefined
12/5/202437.30 undefined
12/4/202437.55 undefined
12/3/202436.70 undefined
12/2/202436.50 undefined
11/29/202436.70 undefined
11/28/202436.30 undefined
11/27/202436.50 undefined
11/26/202436.30 undefined
11/25/202436.70 undefined
11/22/202436.75 undefined
11/21/202436.45 undefined
11/20/202436.15 undefined

Humana Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Humana, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Humana from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Humana’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Humana. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Humana’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Humana’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Humana’s growth potential.

Humana Revenue, EBIT and net profit per share

DateHumana RevenueHumana EBITHumana Net Income
2026e10.09 B undefined606.25 M undefined306.63 M undefined
2025e9.74 B undefined129.95 M undefined243.42 M undefined
2024e10.12 B undefined481.43 M undefined180.73 M undefined
20239.65 B undefined377 M undefined176 M undefined
20229.24 B undefined446 M undefined210 M undefined
20218.19 B undefined508 M undefined276 M undefined
20207.8 B undefined474 M undefined262 M undefined
20197.47 B undefined397 M undefined188 M undefined
20186.73 B undefined414 M undefined246 M undefined
20176.56 B undefined334 M undefined194 M undefined
20166.36 B undefined345 M undefined148 M undefined
20155.66 B undefined384 M undefined28 M undefined
20145.07 B undefined327 M undefined38 M undefined
20133.53 B undefined221.9 M undefined101.5 M undefined
20122.98 B undefined204.1 M undefined44 M undefined
20112.54 B undefined178.2 M undefined2.1 M undefined

Humana Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024e2025e2026e
2.542.983.535.075.666.366.566.737.477.88.199.249.6510.129.7410.09
-17.4118.3843.5311.6512.503.072.5611.034.425.0112.864.424.92-3.763.59
96.5397.3895.75166.81149.41132.80128.85125.64113.15108.3688.6988.2987.5683.4686.7283.71
2.452.93.3800000007.268.168.45000
2441013828148194246188262276210176180243306
-2,100.00129.55-62.38-26.32428.5731.0826.80-23.5839.365.34-23.91-16.192.2735.0025.93
45.945.945.945.8845.8851.5153.1453.1453.1452.9948.747.9647.83000
----------------
Details

Keystats

Revenue and Growth

The Humana Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Humana is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (B)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2011201220132014201520162017201820192020202120222023
                         
130.7196.8291244501465584514836759695690675
0.110.170.240.390.440.520.840.850.830.870.931.031.11
2.48.237597257282933777712284
0000000000000
9157469627401718312747586660
0.330.430.620.791.041.451.531.471.831.751.761.911.93
0.020.060.140.290.20.410.410.562.472.433.033.393.6
0.80.9134689814141816
00000000001021530
11.49.58791310855114037
1.251.231.442.572.583.093.13.173.93.824.154.414.4
00-1011002528413845
1.281.311.582.872.83.513.543.756.46.37.358.058.1
1.611.742.23.663.844.965.065.228.238.049.19.9610.03
                         
1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,000
0.020.070.620.640.641.091.091.091.11.11.11.11.1
0.060.560.230.340.450.630.81.041.191.261.461.641.77
508.90-10-1010-1-1-1022
0000000000000
0.580.630.850.991.091.731.892.132.282.352.552.742.89
21.635.449727910393121129128165187273
0.260.340.440.590.640.70.720.760.920.971.011.121.08
144.4131.3167228283272257229257257279299282
0000000000000
828010673124677680632877813219406743
0.510.590.760.961.131.751.751.742.192.161.672.012.38
0.490.490.541.661.551.411.351.263.673.464.754.66
27.933.94554667873737170745858
0.10.40001-10-10321
0.520.520.591.711.621.481.421.333.743.534.785.064.72
1.021.111.342.672.753.233.173.075.935.696.457.077.1
1.611.742.23.663.844.965.065.28.218.0499.819.99
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Humana provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Humana's financial health and stability.

Assets

Humana's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Humana must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Humana after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Humana's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2011201220132014201520162017201820192020202120222023
11212990156149228250317249332354274231
68811413282506070327371420457538
0000000000000
-54-72-25-185-94-540-135-130-66-164-222-221-295
03901531371016675121122137123147
1328211311029964531211441401650
9397274317030587190727639
127178207156274-161241332631661689633621
-16-23-24-46-46-143-151-174-228-133-107-192-170
-306-96-159-86878-616-60-240-323-37-260-246-151
-290-72-135-822124-47391-66-9596-153-5419
0000000000000
3067047668-93291-49-13451-511-363-370-494
00000442000-156-159-550
149-1647668-93733-75-16614-667-521-424-457
-157-86000010001137
000000-27-32-370000
-296694-46257-36119-71322-78-64-5-15
111155.2182.8110228-30490158403528582441451
0000000000000

Humana stock margins

The Humana margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Humana. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Humana.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Humana's sales revenue. A higher gross margin percentage indicates that the Humana retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Humana's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Humana's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Humana's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Humana. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Humana's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Humana Margin History

Humana Gross marginHumana Profit marginHumana EBIT marginHumana Profit margin
2026e87.56 %6.01 %3.04 %
2025e87.56 %1.33 %2.5 %
2024e87.56 %4.76 %1.79 %
202387.56 %3.91 %1.82 %
202288.29 %4.83 %2.27 %
202188.69 %6.2 %3.37 %
202087.56 %6.08 %3.36 %
201987.56 %5.32 %2.52 %
201887.56 %6.16 %3.66 %
201787.56 %5.09 %2.96 %
201687.56 %5.42 %2.33 %
201587.56 %6.79 %0.5 %
201487.56 %6.46 %0.75 %
201395.73 %6.29 %2.88 %
201297.39 %6.85 %1.48 %
201196.53 %7.02 %0.08 %

Humana Stock Sales Revenue, EBIT, Earnings per Share

The Humana earnings per share therefore indicates how much revenue Humana has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Humana earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Humana's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Humana’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Humana's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Humana Revenue, EBIT and net profit per share

DateHumana Sales per ShareHumana EBIT per shareHumana Earnings per Share
2026e194.73 undefined0 undefined5.92 undefined
2025e187.98 undefined0 undefined4.7 undefined
2024e195.33 undefined0 undefined3.49 undefined
2023201.75 undefined7.88 undefined3.68 undefined
2022192.67 undefined9.3 undefined4.38 undefined
2021168.13 undefined10.43 undefined5.67 undefined
2020147.13 undefined8.94 undefined4.94 undefined
2019140.52 undefined7.47 undefined3.54 undefined
2018126.55 undefined7.79 undefined4.63 undefined
2017123.39 undefined6.29 undefined3.65 undefined
2016123.5 undefined6.7 undefined2.87 undefined
2015123.25 undefined8.37 undefined0.61 undefined
2014110.39 undefined7.13 undefined0.83 undefined
201376.9 undefined4.83 undefined2.21 undefined
201264.96 undefined4.45 undefined0.96 undefined
201155.32 undefined3.88 undefined0.05 undefined

Humana business model

Humana AB is a Swedish company that was founded in 1986 and operates worldwide. The main focus of Humana is to help children and families in need. The company offers various products and services tailored to the needs of the underprivileged. The history of Humana began over three decades ago when a group of women in Sweden came together to collect and distribute clothing and toys for children in need. Over time, the commitment grew and additional projects were launched to support families in need. Since 1993, Humana has been working internationally and has since grown into a large company. The business model of Humana is based on collecting and sorting used clothing and other items. The items are refurbished and then sold in second-hand stores or donated to those in need. The sale of the items not only finances the company, but also conserves resources. The company aims to reduce waste and promote sustainable fashion. Humana is divided into various divisions, all aimed at helping poor and needy individuals and families. These include the second-hand trade, education and social sector, as well as humanitarian aid. In particular, the education sector has gained importance in recent years. An important part of Humana's business model is the second-hand trade. The company collects used clothing and other items, categorizes them according to condition, and sells them in their own stores or through online platforms. The second-hand stores also sell new clothing and products made on a fair-trade basis. The company also employs many individuals who are able to restore and reuse items such as furniture. Humana is also involved in the education and social sector. The company supports schools and kindergartens in obtaining educational materials and toys, thus promoting sustainable education and upbringing. Humana operates various programs to support families and individuals in need, including psychological counseling. In addition, Humana is also involved in humanitarian aid. The company supports people in need in many different countries by supporting humanitarian projects or directly working on-site. For example, Humana provides support for the homeless and those displaced by civil wars. In addition to clothing and accessories, Humana also offers other products that can be purchased in second-hand stores. These include strollers, children's books, toys, as well as household items such as pots, pans, and dishes. The company also has its own fashion line that focuses on environmentally friendly and fairly produced fashion. The products are sold in the company's own second-hand stores and can also be purchased online. In summary, Humana AB is a company that specializes in supporting needy individuals and families worldwide. It operates a core second-hand business and offers clothing and other products at fair prices. Humana is also involved in the education and social sector as well as humanitarian aid, offering various support programs. The company aims to conserve resources and promote sustainable fashion. Humana is one of the most popular companies on Eulerpool.com.

Humana SWOT Analysis

Strengths

Humana AB has several strengths that contribute to its success in the market. Firstly, the company has a strong brand image and reputation, which increases consumer trust and loyalty. Secondly, Humana AB has a wide range of healthcare services and products, allowing it to cater to diverse customer needs. This extensive offering includes primary care, specialist care, and home care services, among others. Additionally, the company has a large network of healthcare professionals, ensuring accessibility and quality care for its customers.

Weaknesses

Despite its strengths, Humana AB also faces certain weaknesses that can hinder its growth. One such weakness is the heavy reliance on government funding for its healthcare programs. This dependence exposes the company to potential changes in government policies or budget cuts. Another weakness is the limited geographical presence of Humana AB, as it primarily operates in a few select regions. This limited reach may hinder its ability to capture a broader market share.

Opportunities

There are several opportunities for Humana AB to explore and expand its business. The growing demand for healthcare services, particularly in the aging population, presents a significant opportunity for the company to increase its market share. Humana AB can leverage its expertise in home care to tap into the expanding market for elderly and chronic care services. Furthermore, the advancement of technology in healthcare, such as telemedicine and digital health solutions, offers Humana AB the opportunity to enhance its service delivery and reach more customers.

Threats

Humana AB also faces various threats that pose risks to its operations and profitability. One major threat is the intense competition within the healthcare industry. Competitors offering similar services and products may attract customers away from Humana AB, reducing its market share. Additionally, regulatory changes in healthcare policies and reimbursement systems can significantly impact the company's financial stability and operations. Lastly, the ongoing COVID-19 pandemic presents a significant threat to Humana AB, as it disrupts normal healthcare practices and imposes additional challenges on service delivery.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Humana Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Humana historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Humana shares outstanding

The number of shares was Humana in 2023 — This indicates how many shares 47.826 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Humana earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Humana's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Humana’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Humana's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Humana dividend history and estimates

In 2023, Humana paid a dividend amounting to 0 SEK. Dividend means that Humana distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Humana provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Humana’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Humana's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Humana Dividend History

DateHumana Dividend
2026e0.97 undefined
2025e0.78 undefined
2024e0.57 undefined
20190.7 undefined
20180.6 undefined
20170.5 undefined

Humana dividend payout ratio

In 2023, Humana had a payout ratio of 16.22%. The payout ratio indicates the percentage of the company's profits that Humana distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Humana represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Humana could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Humana's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Humana Payout Ratio History

DateHumana Payout ratio
2026e16.43 %
2025e16.6 %
2024e16.47 %
202316.22 %
202217.11 %
202116.08 %
202015.48 %
201919.79 %
201812.96 %
201713.7 %
201615.48 %
201515.48 %
201415.48 %
201315.48 %
201215.48 %
201115.48 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Humana.

Humana latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.96 1.82  (-7.11 %)2024 Q3
6/30/20240.49 0.01  (-97.98 %)2024 Q2
12/31/20230.89 0.16  (-82 %)2023 Q4
9/30/20231.46 1.71  (16.76 %)2023 Q3
6/30/20230.7 0.8  (14.79 %)2023 Q2
3/31/20230.04 1.04  (2,474.26 %)2023 Q1
12/31/20221.15 1.24  (7.38 %)2022 Q4
9/30/20222.44 2.17  (-11.04 %)2022 Q3
6/30/20221.04 0.37  (-64.43 %)2022 Q2
12/31/20211.25 0.68  (-45.7 %)2021 Q4
1
2
3

Eulerpool ESG Scorecard© for the Humana stock

Eulerpool World ESG Rating (EESG©)

75/ 100

🌱 Environment

81

👫 Social

99

🏛️ Governance

43

Environment

Scope 1 - Direct Emissions
4,129
Scope 2 - Indirect emissions from purchased energy
1,012
Scope 3 - Indirect emissions within the value chain
25,944
Total CO₂ emissions
5,141
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees71
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Humana shareholders

%
Name
Stocks
Change
Date
25.54201 % Impilo AB13,238,425-90,0005/31/2024
14.32476 % Incentive AS7,424,52306/28/2024
7.71754 % Procuritas AB4,000,0004,000,0006/5/2024
7.71754 % Team Olivia Group AB4,000,0004,000,0006/5/2024
4.03344 % Nordea Funds Oy2,090,53105/31/2024
3.89134 % SEB Investment Management AB2,016,88109/30/2024
2.70158 % Avanza Bank Holding AB1,400,229-237,5745/31/2024
2.13197 % Galba Holding AB1,105,000315,0005/31/2024
1.74035 % Norges Bank Investment Management (NBIM)902,021902,0216/30/2024
1.62693 % Octopus Scott Holding AB843,23838,5005/31/2024
1
2
3
4
5
...
6

Humana Executives and Management Board

Ms. Johanna Rastad

(43)
Humana President, Chief Executive Officer
Compensation 5.29 M

Mr. Fredrik Stroemholm

(57)
Humana Director
Compensation 406,000

Ms. Monica Lingegard

(60)
Humana Independent Director
Compensation 333,000

Ms. Kirsi Komi

(60)
Humana Independent Director
Compensation 302,000

Mr. Anders Nyberg

(67)
Humana Independent Director
Compensation 288,000
1
2
3

Humana Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,910,790,360,370,450,44
SupplierCustomer0,400,670,750,560,470,62
Nordea Bank Abp Stock
Nordea Bank Abp
SupplierCustomer-0,590,010,320,610,430,41
Skandinaviska Enskilda Banken A Stock
Skandinaviska Enskilda Banken A
SupplierCustomer-0,880,28-0,390,700,710,59
1

Most common questions regarding Humana

What values and corporate philosophy does Humana represent?

Humana AB represents a set of values and corporate philosophy focused on enhancing quality of life and promoting well-being. The company prioritizes the needs and preferences of individuals, offering person-centered care solutions. It aims to provide a safe and inclusive environment where everyone is valued and respected. Humana AB is committed to continuous improvement, innovation, and maintaining high ethical standards in all its operations. The company strives to create positive social impact, championing diversity, sustainability, and social responsibility. Humana AB's dedication to excellence and client satisfaction drives its commitment to delivering exceptional healthcare services and support.

In which countries and regions is Humana primarily present?

Humana AB is primarily present in various countries and regions around the world. The company has a strong presence in the Nordic region, including Sweden, Norway, and Finland. It also operates in Europe, with a focus on countries like Germany, the Netherlands, and the United Kingdom. Additionally, Humana AB has expanded its operations to several other countries, such as Russia and Qatar. With its wide geographical footprint, Humana AB has established itself as a prominent player in the healthcare and social services sectors across multiple countries and regions.

What significant milestones has the company Humana achieved?

Humana AB, a premier stock company, has achieved remarkable milestones in its successful journey. With a dedication to excellence, Humana AB has expanded its operations across various sectors, witnessing significant accomplishments over the years. The company has successfully established itself as a leading provider of healthcare and social care services, delivering top-notch quality solutions to its clients. Furthermore, Humana AB has consistently displayed a strong financial performance, demonstrating robust growth and profitability. With its strategic acquisitions and partnerships, Humana AB has expanded its market presence, reinforcing its position as a key player in the industry. Its relentless focus on innovation and customer satisfaction has propelled Humana AB to greater heights, ensuring a bright future ahead.

What is the history and background of the company Humana?

Humana AB is a Swedish company that specializes in providing care and support services for individuals with special needs. Founded in 1993, Humana has grown to become one of the leading companies in the Nordic region, with operations in Sweden, Norway, Finland, Denmark, and Germany. With a strong focus on quality and person-centered care, Humana offers a wide range of services, including housing, home care, and day care. The company is committed to promoting independence, inclusion, and wellbeing for its clients. Over the years, Humana has expanded its services through both organic growth and acquisitions, solidifying its position as a trusted provider in the social care sector.

Who are the main competitors of Humana in the market?

The main competitors of Humana AB in the market include companies such as Aleris, Attendo, Ambea, and Capio.

In which industries is Humana primarily active?

Humana AB is primarily active in the healthcare and social services industries.

What is the business model of Humana?

The business model of Humana AB is focused on providing care and support services to the elderly and individuals with special needs. Through its extensive network of care homes, home care services, and personal assistance, Humana AB aims to ensure that its clients receive the necessary support to maintain their well-being and independence. With a person-centered approach, Humana AB offers customized services tailored to the unique needs of each individual. By offering a range of services such as healthcare, rehabilitation, and social activities, Humana AB strives to enhance the quality of life for those in its care.

What is the P/E ratio of Humana 2024?

The Humana P/E ratio is 9.4.

What is the P/S ratio of Humana 2024?

The Humana P/S ratio is 0.17.

What is the Quality Investing of Humana?

The Quality Investing for Humana is 6/10.

What is the revenue of Humana 2024?

The expected Humana revenue is 10.12 B SEK.

How high is the profit of Humana 2024?

The expected Humana profit is 180.73 M SEK.

What is the business model of Humana

Humana AB is a Swedish company that has been active in the fields of care and health for over 60 years. The company's business model is based on various divisions and products tailored to the needs of patients and those in need of care. One of Humana AB's main business areas is patient care. The company provides specialized, comprehensive, and rehabilitative care to patients in Sweden and Finland. In doing so, the company collaborates with various healthcare and social service providers to offer high-quality treatments to patients. Another important area in which Humana AB operates is human resources. The company offers both temporary and permanent employment contracts for healthcare professionals with different specializations. The needs of the caregivers, patients, and healthcare providers are always at the forefront. Among the products offered by Humana AB are incontinence pads and nursing beds. These products are sold to both patients and healthcare and social service providers. The company places great emphasis on quality and follows the latest standards in the care and health industry. Humana AB also focuses on digital transformation and offers a variety of digital solutions. One of these solutions is the "digital assistant," which allows caregivers to remotely monitor important information such as a patient's health condition or medication. This enables the healthcare personnel to quickly respond to new developments in the patient's condition. Overall, Humana AB's business model is characterized by a clear focus on the needs of patients, caregivers, and healthcare and social service providers. The company not only offers specialized services but also provides products and digital solutions to improve patient care and facilitate the work of caregivers. In summary, Humana AB's business model is geared towards constantly improving patient care. The company relies on a healthy balance of traditional services and innovative digital solutions to ensure the best possible patient care.

What is the Humana dividend?

Humana pays a dividend of 0 SEK distributed over payouts per year.

How often does Humana pay dividends?

The dividend cannot currently be calculated for Humana or the company does not pay out a dividend.

What is the Humana ISIN?

The ISIN of Humana is SE0008040653.

What is the Humana WKN?

The WKN of Humana is A2AFX9.

What is the Humana ticker?

The ticker of Humana is HUM.ST.

How much dividend does Humana pay?

Over the past 12 months, Humana paid a dividend of 0.7 SEK . This corresponds to a dividend yield of about 1.97 %. For the coming 12 months, Humana is expected to pay a dividend of 0.78 SEK.

What is the dividend yield of Humana?

The current dividend yield of Humana is 1.97 %.

When does Humana pay dividends?

Humana pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Humana?

Humana paid dividends every year for the past 3 years.

What is the dividend of Humana?

For the upcoming 12 months, dividends amounting to 0.78 SEK are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is Humana located?

Humana is assigned to the 'Health' sector.

Wann musste ich die Aktien von Humana kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Humana from 5/16/2019 amounting to 0.7 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.

When did Humana pay the last dividend?

The last dividend was paid out on 5/16/2019.

What was the dividend of Humana in the year 2023?

In the year 2023, Humana distributed 0 SEK as dividends.

In which currency does Humana pay out the dividend?

The dividends of Humana are distributed in SEK.

All fundamentals about Humana

Our stock analysis for Humana Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humana Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.